EU QPPV and VP Pharmacovigilance and Epidemiology @ Gilead Sciences
5 free lookup(s). No credit card required.
Anna de Bruyn Location
United Kingdom
Anna de Bruyn Work
now SagePharmaSolutions Ltd
2018 -now EU QPPV and VP Pharmacovigilance and Epidemiology @
2014 -now EU QPPV, Drug Safety and Public Health @
2013 -2014 Interim Executive Director Clinical Safety and Pharmacovigilance @ Daiichi Sankyo Development Ltd
2002 -2004 Research Physician @
2004 -2013 EU QPPV and VP PV @ TGRD Europe
1999 -2002 Director of Clinical Affairs @ Cerbios
Anna de Bruyn Skills
Clinical Trials
Medical Writing
Ich Gcp
Social Media
CRO
Clinical Pharmacology
Neuroscience
Clinical Research
CTMS
Biotechnology
Business Development
Regulatory Affairs
Immunology
Strategy
Pharmacovigilance
Medicine
Clinical Monitoring
Oncology
GCP
Drug Development
Clinical Development
Marketing
Customer Service
Regulatory Submissions
Drug Safety
Therapeutic Areas
Medical Affairs
Public Relations
Research
Anna de Bruyn Summary
Anna de Bruyn, based in United Kingdom, is currently a EU QPPV and VP Pharmacovigilance and Epidemiology at Gilead Sciences. Anna de Bruyn brings experience from previous roles at SagePharmaSolutions Ltd, Gilead Sciences, Daiichi Sankyo Development Ltd and Hammersmith Medicines Research Ltd. With a robust skill set that includes Clinical Trials, Medical Writing, Ich Gcp, Social Media, CRO and more. Anna de Bruyn has 2 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.